March 5, 2016. By Heidi Turner.
Raritan, NJ: Johnson & Johnson (J&J) reportedly faces an $800 million Levaquin lawsuit, alleging the company hid vital information about side effects linked to the drug. Plaintiffs in the Levaquin antibiotic lawsuit allege Johnson & Johnson, and its subsidiary Janssen Pharmaceuticals, deliberately mislabeled Levaquin. In addition to J&J being named in the lawsuit, former FDA commissioner Margaret Hamberg is also listed and faces allegations of violations of the Racketeer Influenced and Corrupt Organizations (RICO) Act.Read [ Johnson & Johnson Faces $800M Levaquin Lawsuit ]
November 17, 2015. By Lucy Campbell.
Santa Clara, CA: Fluoroqinolone antibiotics, including Levaquin, Avelox and Cipro, should have a new black box warning regarding the risk of heart rhythm problems according to Public Citizen, a prominent national watchdog group.Read [ Fluoroqinolone Antibiotics Require Black Box Warning for Heart Rhythm Side Effects ]
July 3, 2015. By Gordon Gibb.
Read [ Levaquin Peripheral Sensorimotor Neuropathy Lawsuits Expected to Grow ]
December 7, 2014. By Heidi Turner.
Read [ Should Levaquin Carry Stronger Warnings? ]
November 14, 2014. By Gordon Gibb.
Read [ Levaquin Peripheral Sensorimotor Neuropathy Strikes a Nerve ]
October 30, 2014. By Gordon Gibb.
Read [ A New Outlaw in the Levaquin Side Effects Corral ]
August 30, 2014. By Brenda Craig.
Read [ The Fluoroquinolones Community—and Their Leader Mark Girard ]
January 24, 2012. By Charles Benson.
Read [ Investment Firm Wants Johnson & Johnson to Be Accountable for Levaquin Side Effects ]
January 14, 2012. By Gordon Gibb.
Read [ Investors Want to Hold J&J's Feet to Levaquin Tendon Fire ]
December 23, 2011. By Jane Mundy.
Read [ Levaquin Nerve Damage Lawsuits Next? ]